Medical Treatment for Methamphetamine Addiction

First-Line Treatment Approach

The American College of Cardiology is not applicable here, however, the most effective treatment for methamphetamine addiction is a combination of contingency management (CM) plus community reinforcement approach (CRA), which has demonstrated superior efficacy and acceptability for both short-term and long-term outcomes compared to other psychosocial interventions, with a number needed to treat (NNT) of 3.7 for abstinence (95% CI 2.4–14.2) 1, 2
Contingency management (CM) plus community reinforcement approach (CRA) is the most effective combined intervention, showing superior outcomes for abstinence at 12 weeks, end of treatment, and longest follow-up after treatment completion, with high treatment retention rates 3, 2
CM involves providing rewards upon drug-free urine samples, while CRA is a multi-layered intervention involving functional analysis, coping-skills training, and social, familial, recreational, and vocational reinforcements, addressing both immediate behavioral reinforcement and underlying psychological and social factors 2

CM alone shows efficacy during treatment but effects are not sustained at long-term follow-up, highlighting the need for a comprehensive approach 4
CRA alone performs similarly to treatment as usual in the short term but shows more sustained effects at follow-up, demonstrating its importance in long-term recovery 4
The combined approach addresses both immediate behavioral reinforcement (CM) and the underlying psychological and social factors (CRA) that maintain addiction, providing a comprehensive treatment for methamphetamine addiction 1
Methamphetamine addiction is conceptualized as a chronic brain disease with behavioral and psychological abnormalities that requires comprehensive treatment, including CM and CRA 4

Cognitive Behavioral Therapy (CBT) alone is more acceptable than treatment as usual but not more efficacious for abstinence, highlighting the need for a multi-faceted approach 3
12-step programs alone are not supported by strong evidence for methamphetamine addiction, and should not be relied upon as the sole treatment approach 2
Non-contingent rewards (providing rewards regardless of drug use status) are not effective, and should be avoided in treatment protocols 4

Currently, there are no FDA-approved medications specifically for methamphetamine use disorder, and psychosocial interventions remain the first-line treatment due to limited evidence supporting pharmacotherapy 2, 5

Treatment should begin promptly upon patient presentation seeking help for methamphetamine addiction, and should be tailored to the individual's needs and circumstances 6
For individuals who inject drugs, both lack of motivation and waiting periods can be barriers to enrollment in treatment programs, and should be addressed through targeted interventions 6
Substance abuse treatment can reduce risk behaviors such as needle-sharing and exchange of sex for money or drugs, and can improve adherence to medical treatment regimens for infectious diseases 6

Relying solely on CM without addressing psychological and social factors, which can lead to relapse and poor treatment outcomes 4
Using non-contingent rewards, which have not shown effectiveness in treating methamphetamine addiction 4
Failing to provide long-term follow-up and support after initial treatment, which is critical for sustained recovery 1